Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

Clinical trial NCT05816720 · COMPLETED

Trial details

NCT number: NCT05816720
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Neuroendocrine Tumor

Start date: 2021-09-01
Primary completion: 2022-01-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.